VolitionRX (VNRX) to Release Earnings on Monday
VolitionRX (NYSEAMERICAN:VNRX) will post its quarterly earnings results after the market closes on Monday, August 12th. Analysts expect VolitionRX to post earnings of ($0.12) per share for the quarter.
VolitionRX (NYSEAMERICAN:VNRX) last released its earnings results on Wednesday, May 8th. The medical research company reported ($0.12) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.12).
VolitionRX stock opened at $3.86 on Friday. VolitionRX has a 1 year low of $1.67 and a 1 year high of $4.65.
VolitionRX Company Profile
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRX Limited is based in Singapore.
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.